Ferrostatin-1

Research use only, not for human use.

Ferrostatin-1 is a potent ferroptosis inhibitor with IC50 of 33 nM.

Ferrostatin-1 is a potent ferroptosis inhibitor with IC50 of 33 nM, inhibits erastin-induced ferroptosis in HT-1080 cells with EC50 of 60 nM; prevents erastin-induced accumulation of cytosolic and lipid ROS, does not inhibit ERK phosphorylation or arrest the proliferation of HT-1080 cells.(In Vitro):Ferrostatin-1 prevents erastin-induced accumulation of cytosolic and lipid ROS. Ferrostatin-1 prevents glutamate-induced neurotoxicity in organotypic rat brain slices.Ferrostatin-1 (2 μM; 24 h) prevents Glutamate (5 mM)-induced neurotoxicity in a rat organotypic hippocampal slice culture (OHSC).Ferrostatin-1 inhibits lipid peroxidation, but not mitochondrial reactive oxygen species formation or lysosomal membrane permeability.Ferrostatin-1 inhibits cell death in cellular models of Huntington's disease (HD), periventricular leukomalacia (PVL), and kidney dysfunction.Ferrostatin-1 (1 μM; 6 h) inhibits the oxidative destruction of unsaturated fatty acids in HT-1080 cells, thus increases the number of healthy medium spiny neurons (MSNs). (In Vivo):Ferrostatin-1 (5 mg/kg; ip; single dose, 30 min before glycerol injection) improves renal function in mice with rhabdomyolysis, whereas no beneficial effects were observed with the pan-caspase inhibitor zVAD or in RIPK3-deficient mice.Ferrostatin-1 (0.8 mg/kg; tail vein injection) effectively alleviates LPS-induced induced acute lung injury (ALI).Ferrostatin-1 (i.p.; 5 mg/kg; C57BL/6J mice) improves renal function in mice with rhabdomyolysis.

——

Animal Model:Male C57BL/6 mice (LPS-induced ALI)Dosage:0.8?mg/kg Administration:Tail vein injection Result:Exerted therapeutic action against LPS-induced ALI.

Ferrostatin 1

Apoptosis

Ferroptosis

Ferroptosis

Cancer

——

347174-05-4

262.353

C15H22N2O2

>98% (HPLC)

DMSO: 26.2 mg/mL (100 mM); Ethanol: 26.2 mg/mL (100 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )

O=C(OCC)C1=CC=C(NC2CCCCC2)C(N)=C1

ethyl 3-amino-4-(cyclohexylamino)benzoate

(-20℃)

With Ice Pack

≥ 2 years